Elevated circulating vascular cell Adhesion Molecule-1 (sVCAM-1) is associated with concurrent depressive symptoms and cerebral white matter Hyperintensities in older adults

[1]  R. de Cabo,et al.  Mechanisms of vascular aging: new perspectives. , 2010, The journals of gerontology. Series A, Biological sciences and medical sciences.

[2]  Jong S. Kim.  Cytokines and adhesion molecules in stroke and related diseases , 1996, Journal of the Neurological Sciences.

[3]  S. J. Cashman,et al.  Soluble Forms of Vascular Adhesion Molecules, E‐Selectin, ICAM‐1, and VCAM‐1: Pathological Significance , 1992, Annals of the New York Academy of Sciences.

[4]  J T O'Brien,et al.  Elevation in late-life depression of intercellular adhesion molecule-1 expression in the dorsolateral prefrontal cortex. , 2000, The American journal of psychiatry.

[5]  A. Jette,et al.  The Physical Activity Scale for the Elderly (PASE): development and evaluation. , 1993, Journal of clinical epidemiology.

[6]  M. Glymour,et al.  Depressive symptoms predict incident stroke independently of memory impairments , 2010, Neurology.

[7]  D. Alsop,et al.  Adhesion Molecules, Altered Vasoreactivity, and Brain Atrophy in Type 2 Diabetes , 2011, Diabetes Care.

[8]  P. Crean,et al.  Prediction of cardiovascular risk using soluble cell adhesion molecules. , 2002, European heart journal.

[9]  M. Trimble,et al.  Neuropsychiatric symptoms from the temporolimbic lobes. , 1997, The Journal of neuropsychiatry and clinical neurosciences.

[10]  Farzaneh A. Sorond,et al.  Neurovascular coupling is impaired in slow walkers: The MOBILIZE Boston Study , 2011, Annals of neurology.

[11]  Douglas R Seals,et al.  Aging and vascular endothelial function in humans. , 2011, Clinical science.

[12]  Jagmeet P. Singh,et al.  Depression as a predictor for appropriate shocks among patients with implantable cardioverter-defibrillators: results from the Triggers of Ventricular Arrhythmias (TOVA) study. , 2005, Journal of the American College of Cardiology.

[13]  Farzaneh A. Sorond,et al.  The MOBILIZE Boston Study: Design and methods of a prospective cohort study of novel risk factors for falls in an older population , 2008, BMC geriatrics.

[14]  Karl J. Friston,et al.  The anatomy of melancholia – focal abnormalities of cerebral blood flow in major depression , 1992, Psychological Medicine.

[15]  J. Escobar,et al.  Use of the Mini-Mental State Examination (MMSE) in a Community Population of Mixed Ethnicity: Cultural and Linguistic Artifacts , 1986, The Journal of nervous and mental disease.

[16]  A. Popa-Wagner,et al.  Perfusion deficits, inflammation and aging precipitate depressive behaviour , 2014, Biogerontology.

[17]  A L Dannenberg,et al.  Physical activity and depressive symptoms: the NHANES I Epidemiologic Follow-up Study. , 1988, American journal of epidemiology.

[18]  A. Gotto,et al.  Levels of soluble cell adhesion molecules in patients with dyslipidemia. , 1996, Circulation.

[19]  J. Billard,et al.  Mechanisms underlying the neuroprotective effect of brain reserve against late life depression , 2015, Journal of Neural Transmission.

[20]  L. Berkman,et al.  Two Shorter Forms of the CES-D Depression Symptoms Index , 1993 .

[21]  Suzanne G. Leveille,et al.  American Journal of Epidemiology Practice of Epidemiology Issues in Conducting Epidemiologic Research among Elders: Lessons from the Mobilize Boston Study , 2022 .

[22]  Farzaneh A. Sorond,et al.  Impaired Cerebrovascular Hemodynamics are Associated with Cerebral White Matter Damage , 2014, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[23]  K. Krishnan,et al.  MRI-defined vascular depression. , 1997, The American journal of psychiatry.

[24]  J. O'Brien,et al.  Glial fibrillary acidic protein in late life major depressive disorder: an immunocytochemical study , 2002, Journal of neurology, neurosurgery, and psychiatry.

[25]  L. Berkman,et al.  Two shorter forms of the CES-D (Center for Epidemiological Studies Depression) depression symptoms index. , 1993, Journal of aging and health.

[26]  M. Weissman,et al.  Assessing depressive symptoms in five psychiatric populations: a validation study. , 1977, American journal of epidemiology.

[27]  H. González,et al.  Comorbid cardiovascular disease and major depression among ethnic and racial groups in the United States , 2013, International Psychogeriatrics.

[28]  L. Fried,et al.  Depressive Symptoms, Inflammation, and Ischemic Stroke in Older Adults: A Prospective Analysis in the Cardiovascular Health Study , 2007, Journal of the American Geriatrics Society.

[29]  A. Gearing,et al.  Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells. , 1992, Biochemical and biophysical research communications.

[30]  D. Phillips,et al.  PECAM-1 is required for transendothelial migration of leukocytes , 1993, The Journal of experimental medicine.

[31]  M. Schwarz,et al.  Correlation between sICAM-1 and depressive symptoms during adjuvant treatment of melanoma with interferon-α , 2004, Brain, Behavior, and Immunity.

[32]  R. Hales,et al.  J Neuropsychiatry Clin Neurosci , 1992 .

[33]  J. Rumsfeld,et al.  Depressive symptoms and health-related quality of life: the Heart and Soul Study. , 2003, JAMA.

[34]  A. Gearing,et al.  Circulating adhesion molecules in disease. , 1993, Immunology today.

[35]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[36]  S. Thielke,et al.  Prevalence, incidence, and persistence of major depressive symptoms in the Cardiovascular Health Study , 2010, Aging & mental health.

[37]  V. Vaccarino,et al.  Cardiovascular disease, psychosocial factors, and genetics: the case of depression. , 2013, Progress in cardiovascular diseases.

[38]  G. Alexopoulos,et al.  'Vascular depression' hypothesis. , 1997, Archives of general psychiatry.